Shifang Yang

机构：Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Southern Medical University · ORCID：0009-0005-7025-4473

发表论文 44 篇 · 总被引 706 次 · h-index 15

代表论文

• A study on infectivity of asymptomatic SARS-CoV-2 carriers (2020 · Respiratory Medicine · 被引 155)
• Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data (2024 · Journal of Infection · 被引 54)
• Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study (2017 · Cancer Chemotherapy and Pharmacology · 被引 32)
• Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages (2021 · Sleep And Breathing · 被引 23)
• The association between ambient temperature and antimicrobial resistance of Klebsiella pneumoniae in China: a difference-in-differences analysis (2023 · Frontiers in Public Health · 被引 18)
• Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial (2023 · BMC Cancer · 被引 17)